BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...

A new study has shown that person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) ...

Genmab’s antibody drug conjugate (ADC) rinatabart sesutecan (Rina-S) demonstrated positive efficacy in treating patients with ...

A new study has shown that person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) ...

Agenus, which has been going through a reorganization after the FDA put the brakes on the biotech's regulatory plan for its ...

Two-Part Dose Escalation and Expansion Trial Will Evaluate Efficacy and Safety of BYON4228 Alone and in Combination with Pembrolizumab NIJMEGEN, The ...

This decision came after the company entered into an agreement with Bristol Myers Squibb for the co-development and ...

The new treatment will deliver chemotherapy directly to cancer cells. Read more at straitstimes.com. Read more at ...

Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...

A groundbreaking study has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161 ...

RSV leads to over 100,000 infant deaths annually, but WHO’s latest guidance recommends maternal vaccines and monoclonal ...